EGFR and anemia: A 69‐year‐old woman with advanced‐stage EGFR mutation‐positive lung adenocarcinoma developed persistent diarrhoea 3 weeks after starting osimertinib, complicated by anorexia, hypotension, anaemia and renal failure requiring hospitalisation.